Development and evaluation of an internet-based psychological support program for parents caring for a child with CF
Not Applicable
- Conditions
- F41.1F43F41.2Reaction to severe stress, and adjustment disordersGeneralized anxiety disorderMixed anxiety and depressive disorder
- Registration Number
- DRKS00004451
- Lead Sponsor
- niversitätsklinikum Ulm, Klinik für Kinder- und Jugendpsychiatrie/Psychotherapie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 31
Inclusion Criteria
caregiver of a minor child (0-17 years) with a confirmed diagnosis of CF
- have a score = 8 points on the HADS Anxiety subscale
- have permanent access to a computer with internet connection
- be able to read and write fluent German
Exclusion Criteria
- acute suicidality
- psychotic symptoms
- concurrent psychotherapy
- change in psychotropic medication six weeks before the start of the treatment and during treatment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary endpoint is the reduction of anxious symptoms measured online with the Anxiety Subscale of the Hospital Anxiety and Depression Scale (HADS, Zigmond & Snaith) at baseline (before the intervention), after completion of the last treatment session and three month after completion of the intervention program.
- Secondary Outcome Measures
Name Time Method Secondary endpoints are the reduction of illness related fears (measured with an adapted version of the Fear of Progression Questionnaire, FoP-Q, Herschbach et al.), the reduction of depressive symptoms (Center for Epidemiological Studies Depression Scale CES, German Version: ADS-K, Hautzinger & Bailer), the improvement of the parents`quality of life (Ulm quality of life inventory for parents of chronically ill children, Goldbeck & Storck) and coping skills (Coping Health Inventory for Parents, CHIP, German Version, McCubbin & McCubbin). All questionnaires are administered online at baseline, after completion of the last treatment session and three month after completion of the intervention program. Additionally, the acceptance of the intervention is evaluated at the end of treatment. For this purpose a short questionnaire was developed.